rethinkPeptides Search
Menu
Home / Research library
Study breakdown

BPC-157 Cream Overcomes Steroid-Impaired Wound Healing in Burned Mice

RPEP-008582003Sikiric, P; Seiwerth, S; Mise, S; Staresinic, M; Bedekovic, V; Zarkovic, N; Borovic, S; Gjurasin, M; Boban-Blagaic, A; Batelja, L; Rucman, R; Anic, T
Animal StudyModerate evidence
The takeaway

Topical BPC-157 cream reversed corticosteroid-induced healing impairment in burn wounds, restoring wound closure rates even during ongoing steroid treatment — addressing a major clinical problem.

Steroid healing rescued

BPC-157 cream restored wound healing to near-normal during ongoing steroid treatment — counteracting corticosteroids' most problematic side effect

What the researchers found

Topical BPC-157 cream reversed methylprednisolone-induced burn wound healing impairment in mice, restoring wound closure rates during concurrent steroid treatment.

Why it matters

Millions of patients need corticosteroids but suffer from impaired healing. A cream that reverses steroid-induced healing failure without interfering with steroid therapy fills a critical clinical gap.

How the study worked

Animal study in burned mice receiving methylprednisolone. BPC-157 cream applied topically to burn wounds. Wound healing rate (contraction, re-epithelialization) measured at multiple timepoints versus steroid-treated controls.

What this study cannot tell us

Mouse burn model with specific steroid protocol. Human steroid-impaired wounds may respond differently. Optimal BPC-157 cream concentration not established.

How to read the evidence

Moderate evidence from a controlled animal study directly addressing the clinically relevant problem of steroid-impaired burn healing.

When this study was published

Published in 2003. BPC-157 was noted as being in early clinical trials for IBD at the time. Wound healing applications continue to be developed.

The bigger picture

Steroid-impaired healing is one of medicine's most common wound complications. BPC-157 cream addressing this directly — at the wound surface during ongoing steroid therapy — has enormous practical potential.

Questions still open

  • Could BPC-157 cream be used for steroid-dependent patients' surgical wounds?
  • Does it work for chronic steroid-impaired wounds (not just burns)?
  • What cream formulation and concentration are optimal?

Common questions

Can BPC-157 cream help wounds that won't heal on steroids?
In mice, yes — dramatically. BPC-157 cream restored healing that steroids had blocked. For patients who need steroids but have wounds (surgical patients, burn patients), this could be transformative.
Does the steroid still work while BPC-157 heals?
Yes — BPC-157 reversed the healing impairment without interfering with steroid therapy. Patients could continue their needed steroid treatment while their wounds heal normally.

Read the original research

Corticosteroid-impairment of healing and gastric pentadecapeptide BPC-157 creams in burned mice.

Burns : journal of the International Society for Burn Injuries, 29(4), 323-34

View on PubMed ↗

Citation

Sikiric, P; Seiwerth, S; Mise, S; Staresinic, M; Bedekovic, V; Zarkovic, N; Borovic, S; Gjurasin, M; Boban-Blagaic, A; Batelja, L; Rucman, R; Anic, T. (2003). Corticosteroid-impairment of healing and gastric pentadecapeptide BPC-157 creams in burned mice.. Burns : journal of the International Society for Burn Injuries, 29(4), 323-34.